29
Participants
Start Date
August 18, 2021
Primary Completion Date
October 24, 2023
Study Completion Date
October 24, 2023
PF-07257876
CD47-PDL-1 bispecific antibody
Magee-Womens Hospital of UPMC, Pittsburgh
UPMC Hillman Cancer Center, Pittsburgh
UPMC Shadyside Hospital, Pittsburgh
UPMC Hillman Cancer Center Erie, Erie
UPMC Hillman Cancer Center - Camp Hill, Camp Hill
UPMC Hillman Cancer Center - Carlisle, Carlisle
UPMC Pinnacle - Ortenzio Cancer Center (OCC), Mechanicsburg
UPMC Pinnacle - Community Osteopathic / Medical Sciences Pavilion (MSP), Harrisburg
UPMC Memorial, York
Virginia Cancer Specialists, Fairfax
Duke Cancer Institute, Durham
Hospital General Universitario Gregorio Marañon, Madrid
Hospital Universitario 12 de Octubre, Madrid
Mayo Clinic Jacksonville, Jacksonville
Hospital Clinico de Valencia, Valencia
Mayo Clinic Rochester, Rochester
Siteman Cancer Center-North County, Florissant
Barnes-Jewish Hospital, St Louis
Washington University School of Medicine, St Louis
Washington University, St Louis
Siteman Cancer Center - South County, St Louis
Siteman Cancer Center - West County, Creve Coeur
Siteman Cancer Center - St Peters, City of Saint Peters
Highlands Oncology Group, Fayetteville
Highlands Oncology Group, Rogers
Highlands Oncology Group, Springdale
Mayo Clinic Hospital, Phoenix
Mayo Clinic, Scottsdale
The Angeles Clinic and Research Institute, A Cedars-Sinai Affiliate, Los Angeles
Keck Hospital of USC, Los Angeles
Keck School of Medicine of USC, Los Angeles
LAC+USC Medical Center, Los Angeles
USC/Norris Comprehensive Cancer Center, Los Angeles
The Angeles Clinic and Research Institute, A Cedars-Sinai Affiliate (Emergency Back-Up Only), Santa Monica
Keck Hospital of USC Pasadena, Pasadena
Hoag Hospital Irvine, Irvine
Hoag Memorial Hospital Presbyterian, Newport Beach
Seattle Cancer Care Alliance, Seattle
Hackensack University Medical Center, Hackensack
John Theurer Cancer Center at Hackensack University Medical Center, Hackensack
Rhode Island Hospital, Providence
The Miriam Hospital, Providence
Hospital Universitari Vall d'Hebron, Barcelona
Lead Sponsor
Pfizer
INDUSTRY